Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 


Upcoming Unit Investment Trust Deposits
Portfolio Name Ticker Initial Offer Date Cash CUSIP(s) Reinvest CUSIP(s) Term
Capital Strength Opportunity, 12 FHLUYX 1/27/2020
30312V101
30312V127 (Fee)
30312V119
30312V135 (Fee)
15 Month
Capital Strength, 50 FKUSZX 1/27/2020
30312V143
30312V168 (Fee)
30312V150
30312V176 (Fee)
2 Year
Tax-Advantaged Municipal Closed-End, 59 FKLBWX 1/27/2020
30313C185
30313C201 (Fee)
30313C193
30313C219 (Fee)
2 Year
U.S. Revenue, 17 FFZEMX 1/27/2020
30312Y543
30312Y568 (Fee)
30312Y550
30312Y576 (Fee)
2 Year
Balanced Income Equity and ETF, 41 FGSMSX 1/28/2020
30312Y782
30312Y808 (Fee)
30312Y790
30312Y816 (Fee)
2 Year
Senior Loan Closed-End and ETF, 30 FIFDEX 1/28/2020
30312Y303
30312Y329 (Fee)
30312Y311
30312Y337 (Fee)
2 Year
Alternative Income, 36 FJRTQX 1/29/2020
30312Y824
30312Y840 (Fee)
30312Y832
30312Y857 (Fee)
2 Year
Covered Call Select Closed-End, 75 FGIVPX 1/29/2020
30313C441
30313C466 (Fee)
30313C458
30313C474 (Fee)
2 Year
Global Dividend, 62 FKBKTX 1/29/2020
30313A106
30313A122 (Fee)
30313A114
30313A130 (Fee)
2 Year
Strategic Income Advantage Opportunity, Closed-End, 18 FFPNJX 1/29/2020
30313A148
30313A163 (Fee)
30313A155
30313A171 (Fee)
15 Month
Sabrient Baker's Dozen, 1st Qtr 2020 Series B FLOBFX 1/30/2020
30313E587
30313E603 (Fee)
30313E595
30313E611 (Fee)
15 Month
Election, 14 FHVMBX 1/31/2020
30312V580
30312V606 (Fee)
30312V598
30312V614 (Fee)
16 Month
Financials Select, 71 FJICNX 1/31/2020
30313A304
30313A320 (Fee)
30313A312
30313A338 (Fee)
2 Year
New Jersey & New York Municipal Income Select Closed-End, 4 FHCDVX 1/31/2020
30313A460
30313A486 (Fee)
30313A478
30313A494 (Fee)
2 Year
New York Municipal Income Select Closed-End, 57 FIOUHX 1/31/2020
30313C227
30313C243 (Fee)
30313C235
30313C250 (Fee)
2 Year
SMid High Dividend, 37 FIYLKX 1/31/2020
30312Y345
30312Y360 (Fee)
30312Y352
30312Y378 (Fee)
2 Year
Utilities Select, 54 FCQGLX 1/31/2020
30313A429
30313A445 (Fee)
30313A437
30313A452 (Fee)
2 Year
Contrarian Large-Cap Value, 4 ------- 2/3/2020
30313C326
30313C342 (Fee)
30313C334
30313C359 (Fee)
15 Month
High-Yield Income Closed-End, 88 ------- 2/3/2020
30313C482
30313C508 (Fee)
30313C490
30313C516 (Fee)
2 Year
Equity Closed-End, 57 ------- 2/5/2020
30313A502
30313A528 (Fee)
30313A510
30313A536 (Fee)
2 Year
Health Care Select, 57 ------- 2/5/2020
30313A346
30313A361 (Fee)
30313A353
30313A379 (Fee)
2 Year
MLP Closed-End Fund and Energy, 67 ------- 2/5/2020
30313A189
30313A205 (Fee)
30313A197
30313A213 (Fee)
2 Year
Municipal Income Select, Closed-End, 110 ------- 2/5/2020
30313E462
30313E488 (Fee)
30313E470
30313E496 (Fee)
2 Year
FT Income, 6 ------- 2/6/2020
30313A221
30313A247 (Fee)
30313A239
30313A254 (Fee)
15 Month
Global Equity Income Closed-End, 69 ------- 2/7/2020
30313C565
30313C581 (Fee)
30313C573
30313C599 (Fee)
2 Year
Dividend & Income Select Closed-End, 79 ------- 2/10/2020
30312Y584
30312Y600 (Fee)
30312Y592
30312Y618 (Fee)
2 Year
Dow® Target 10, February 2020 ------- 2/10/2020
30312V226
30312V242 (Fee)
30312V234
30312V259 (Fee)
13 Month
Innovative Health Care Portfolio, 3 ------- 2/10/2020
30313C367
30313C383 (Fee)
30313C375
30313C391 (Fee)
15 Month
Pacific Northwest, 4 ------- 2/10/2020
30313C284
30313C300 (Fee)
30313C292
30313C318 (Fee)
15 Month
Corporate Investment Grade, 3-7 Year,12 ------- 2/11/2020
30313C268
30313C276 (Wrap)
TBD
Banking Opportunity, 37 ------- 2/14/2020
30313A544
30313A569 (Fee)
30313A551
30313A577 (Fee)
15 Month
Cloud Computing, 28 ------- 2/14/2020
30313A700
30313A726 (Fee)
30313A718
30313A734 (Fee)
2 Year
Strategic Income Closed-End, 76 ------- 2/14/2020
30313C607
30313C623 (Fee)
30313C615
30313C631 (Fee)
2 Year
Strategic International Opportunity, 12 ------- 2/14/2020
30313C409
30313C425 (Fee)
30313C417
30313C433 (Fee)
15 Month
Automated Quantitative Analysis, 20 ------- 2/18/2020
30312V622
30312V648 (Fee)
30312V630
30312V655 (Fee)
2 Year
Dividend Strength Opportunity, 12 ------- 2/18/2020
30313A742
30313A767 (Fee)
30313A759
30313A775 (Fee)
15 Month
Municipal Income Opportunities Closed-End, 60 ------- 2/18/2020
30313A262
30313A288 (Fee)
30313A270
30313A296 (Fee)
15 Month
SMid Capital Strength Opportunity, 12 ------- 2/18/2020
30313C524
30313C540 (Fee)
30313C532
30313C557 (Fee)
15 Month
Cboe Vest Large Cap Buffered, 4 ------- 2/19/2020
30313C722
30313C730 (Fee)
15 Month
Core Holdings Growth, Spring 2020 ------- 2/19/2020
30312Y261
30312Y287 (Fee)
30312Y279
30312Y295 (Fee)
2 Year
Limited Duration Fixed Income ETF, 34 ------- 2/20/2020
30313C649
30313C664 (Fee)
30313C656
30313C672 (Fee)
2 Year
Municipal Advantage Closed-End and ETF, 58 ------- 2/20/2020
30313C748
30313C763 (Fee)
30313C755
30313C771 (Fee)
2 Year
Cybersecurity, 19 ------- 2/21/2020
30313A783
30313A809 (Fee)
30313A791
30313A817 (Fee)
2 Year
Defensive Equity, 52 ------- 2/21/2020
30313A825
30313A841 (Fee)
30313A833
30313A858 (Fee)
2 Year
Dorsey Wright Relative Strength Dividend, 38 ------- 2/21/2020
30313A627
30313A643 (Fee)
30313A635
30313A650 (Fee)
15 Month
Dorsey Wright Relative Strength Top 50, 38 ------- 2/21/2020
30313A668
30313A684 (Fee)
30313A676
30313A692 (Fee)
15 Month
Energy Select, 75 ------- 2/24/2020
30313C789
30313C805 (Fee)
30313C797
30313C813 (Fee)
2 Year
High Dividend Equity Allocation, 35 ------- 2/24/2020
30313C821
30313C847 (Fee)
30313C839
30313C854 (Fee)
2 Year
U.S. Infrastructure, 20 ------- 2/24/2020
30313E108
30313E124 (Fee)
30313E116
30313E132 (Fee)
2 Year
S&P/Drucker Institute Corporate Effectiveness, 2 ------- 2/25/2020
30313E140
30313E165 (Fee)
30313E157
30313E173 (Fee)
15 Month
Cyclical Strength, 29 ------- 2/26/2020
30313E181
30313E207 (Fee)
30313E199
30313E215 (Fee)
2 Year
Water Utility & Infrastructure Select, 57 ------- 2/26/2020
30313E223
30313E249 (Fee)
30313E231
30313E256 (Fee)
2 Year
MLP Closed-End, 29 ------- 2/28/2020
30313E264
30313E280 (Fee)
30313E272
30313E298 (Fee)
2 Year
Dow® Target 10, January 2020 ------- 3/10/2020
30313C102
30313C128 (Fee)
30313C110
30313C136 (Fee)
13 Month


 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial advisors are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2020 All rights reserved.